{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-083043","form_type":"8-K","ticker":"BEAM","cik":"0001745999","company_name":"Beam Therapeutics Inc.","filed_at":"2025-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.571242+00:00","generated_at":"2026-05-19T18:29:05.144762+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Beam Therapeutics shareholders elect directors, ratify Deloitte, approve say-on-pay","bullets":["Elected Mark Fishman (61.9M for, 10.3M against), Carole Ho (71.7M for), and Kathleen Walsh (71.9M for) as Class II directors.","Ratified Deloitte & Touche as independent auditor for FY2025 with 84.3M for, 154K against, 63.6K abstentions.","Advisory vote on named executive officer compensation approved: 71.7M for, 562.9K against, 33.9K abstentions.","All proposals passed; broker non-votes were 12.2M on director elections and say-on-pay."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-083043","json":"https://secwatch.observer/filing/0000950170-25-083043.json","markdown":"https://secwatch.observer/filing/0000950170-25-083043.md","text":"https://secwatch.observer/filing/0000950170-25-083043.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025083043/0000950170-25-083043-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025083043/beam-20250604.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T18:29:05.144762+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}